P392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI-PROLIFERATIVE AND NOVEL ANTI-TUMOR IMMUNE RESPONSES IN AML

• L. A. Carvajal,
• B. Robinson,
• Y. Kosaka,
• T. Jacob,
• J. Lee,
• T. Hood,
• K. Baker,
• A. Kaempf,
• S. N.-A. Amara,
• J. Pucilowska,
• E. Lind,
• C. Tognon,
• J. Tyner,
• P. Kumar,
• T. Vu,
• J. DiMartino

Affiliations

L. A. Carvajal

1 Kronos Bio, Inc., San Mateo

B. Robinson

2 Oregon Health & Science University (OHSU), Portland, United States of America

Y. Kosaka

2 Oregon Health & Science University (OHSU), Portland, United States of America

T. Jacob

2 Oregon Health & Science University (OHSU), Portland, United States of America

J. Lee

2 Oregon Health & Science University (OHSU), Portland, United States of America

T. Hood

1 Kronos Bio, Inc., San Mateo

K. Baker

2 Oregon Health & Science University (OHSU), Portland, United States of America

A. Kaempf

2 Oregon Health & Science University (OHSU), Portland, United States of America

S. N.-A. Amara

1 Kronos Bio, Inc., San Mateo

J. Pucilowska

2 Oregon Health & Science University (OHSU), Portland, United States of America

E. Lind

2 Oregon Health & Science University (OHSU), Portland, United States of America

C. Tognon

2 Oregon Health & Science University (OHSU), Portland, United States of America

J. Tyner

2 Oregon Health & Science University (OHSU), Portland, United States of America

P. Kumar

1 Kronos Bio, Inc., San Mateo

T. Vu

2 Oregon Health & Science University (OHSU), Portland, United States of America

J. DiMartino

1 Kronos Bio, Inc., San Mateo